Hoth Therapeutics, Inc.
HOTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $9 | $15 |
| - Cash | $7 | $9 | $6 | $9 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2 | -$4 | $3 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$0 | $0 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$8 | -$11 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.28 | -2.3 | -9.5 | -16.03 |
| % Growth | 44.3% | 75.8% | 40.7% | – |
| Operating Cash Flow | -$7 | -$8 | -$9 | -$12 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$7 | -$8 | -$9 | -$12 |